Tag: <span>CAR-T treatment</span>

Home / CAR-T treatment
Post

‘Real world’ data on Yescarta for lymphoma look slightly worse than initial study results

Doctors treating lymphoma patients with the CAR-T therapy Yescarta in the “real world” are seeing results that are slightly worse than data collected in the pivotal clinical trial conducted by Kite Pharma, now a part of Gilead Sciences. But the analysis may have been affected by the inclusion of sicker patients who would have been...